A trial by Pfizer has shown that its antiviral pill for COVID-19 was effective against the disease and reduces by 89 per cent the chances of hospitalization or death for adults at risk of developing severe disease. The pill was more effective than that of Merck & Co Inc’s Molnupiravir which has been shown to …

The post Pfizer’s new pull up to 89 percent effective against COVID-19 appeared first on The Filipino Times.